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Introduction: Fragile X syndrome is the most common form of inherited mental 
retardation in humans, caused by an expansion of the (CGG) repeat in the FMR1 gene 
located on X chromosome. Males carrying a full mutation are always mentally 
retarded, whereas females carrying a full mutation show mild to moderate mental 
impairment in only approximately 60% of cases, due to the X-inactivation process. 
The absence of the FMR1 gene product, FMRP, in the brain is hypothesized as 
causative for the observed mental retardation in fragile X patients. Antibody tests 
have been developed to identify fragile X patients, based on the presence or absence 
of FMRP in both lymphocytes and hair roots. It has been proposed that FMRP 
expression in hair roots from females carrying a full mutation may be used as a 
prognostic value for the mental capacities. Hair roots originate from the ectoderm, 
like brain tissue, and may therefore show a better correlation between FMRP 
expression and cognitive functioning than FMRP expression in lymphocytes, which 
originate from the mesoderm.  
Objectives: This study focussed on the relationship of the antibody test for cognitive 
functioning in females carrying a full mutation using either hair roots or bloodsmears.   
Method: Thirty samples from females carrying either a normal, premutation or full 
mutation were included in this study. All subjects were selected from an Indonesian 
fragile X family. The analyses were performed in a blind fashion. All subjects were 
tested for FMRP expression in lymphocytes and hair roots using the antibody test. 
Classification of the genotypes of the subjects was obtained by Southern blot 
analysis. IQ equivalent were determined using Standard Progressive Matrices (SPM) 
from Raven, a non-verbal IQ-test. Statistical analysis to show the correlation of 
FMRP expression and IQ equivalent was developed using Pearson correlation. 
Result: We report a significant relationship between FMRP expression in hair roots 
and cognitive functioning in female carriers of the fragile X full mutation (r=0.64, 
p=0.015) whereas in lymphocytes no significant relationship could be established 
(r=0.31, p= 0.281). We also reported that FMRP expression in blood smear was 
relatively higher than hair roots. We also demonstrated in our study group that IQ 
equivalents were about 14 % in normal range, 7 % in the borderline range and 79 % 
in mild mental impairment range. 
Conclusion: Although the size of our study group was limited the results suggest that 
FMRP expression in cell of hair roots has stronger correlation for cognitive 










Pendahuluan: Sindrom Fragile X adalah bentuk retardasi mental diturunkan yang 
paling sering ditemukan pada manusia, yang disebabkan oleh perpanjangan kodon 
CGG di gene FMR1 yang berlokasi di kromosom X. Pria pembawa alel full mutasi 
umumnya akan menderita retardasi mental sedangkan wanita pembawa full mutasi 
menunjukan gejala retardasi mental dari tingkat rendah sampai sedang sekitar 60 % 
dari kasus, karena proses inaktivasi kromosom X. Ketidakadaan produk gen FMR1 
yaitu FMRP, dipercaya sebagai penyebab dari kejadian retadasi mental pada pasien-
pasien sindroma fragile X. Tes antibody untuk mengidentifikasi pasien sindrome 
fragile X telah dikembangkan berdasarkan pada ada atau tidak adanya ekspresi 
protein FMRP pada limposit dan akar rambut. Ekspresi protein FMRP pada akar 
rambut dari wanita pembawa alel full mutasi telah dilaporkan dapat digunakan 
sebagai nilai prognostik untuk menilai kapasitas mental. Akar rambut yang berasal 
dari jaringan ektoderm seperti halnya jaringan otak diharapkan menunjukan korelasi 
yang lebih baik antara ekspresi FMRP dan fungsi kognitif dari pada ekspresi FMRP 
di limposit yang berasal dari jaringan mesoderm.  
Tujuan:  Studi ini memfokuskan pada hubungan test antibodi dengan fungsi 
kognitive pada wanita fragile X pembawa kelainan full mutasi  dengan menggunakan 
jaringan akar rambut atau hapusan darah. 
Metode: Tiga puluh sample baik yang normal, pembawa kelainan premutasi atau 
fullmutasi diikutkan dalam studi ini. Semua subjek diseleksi dari keluarga yang 
diketahui mempunyai riwayat sindrom fragile X. Analisis dilakukan dengan metode 
blind fashion. Semua subjek dilakukan tes untuk menunjukan ekspresi protein FMRP 
pada limposit dan akar rambut menggunakan tes antibody. Klasifikasi genotip dari 
subjek didapat dengan menggunakan analisis Southerb blot. IQ equivalent dari subjek 
ditentukan dengan menggunakan Standard Progressive Matrices (SPM) dari Raven, 
yang merupakan tes IQ non-verbal. Analisa statistik untuk menunjukan korelasi 
antara ekspresi FMRP dan IQ equivalent digunakan korelasi Pearson. 
Hasil: Studi menunjukan korelasi yang signifikan antara ekspresi FMRP pada akar 
rambut dan fungsi kognitif pada wanita pembawa kelainan full mutasi (r=0.64, 
p=0.015), sedangkan pada ekspresi FMRP di limposit tidak menunjukan korelasi 
yang signifikan (r=0.31, p= 0.281). Studi ini juga menunjukan bahwa ekspresi FMRP 
di darah apus relatif lebih tinggi dari pada akar rambut. Distribusi IQ equivalent pada 
keseluruhan subjek adalah kurang lebih 14 % di kisaran normal, 7 % di kisaran 
borderline dan 79 % di kisaran sedang. 
Kesimpulan:  Meskipun jumlah subjek dari penelitian ini sedikit, hasil penelitian 
menunjukan bahwa eksresi FMRP pada sel akar rambut menunjukan nilai korelasi 
yang lebih kuat untuk fungsi kognitif pada wanita pembawa kelainan full mutasi dari 
pada ekspresi FMRP di hapusan darah. 
 
Kata kunci: Sindroma fragile X, wanita pembawa full mutasi, FMRP, fungsi kognitif  
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 CHAPTER I  
INTRODUCTION 
 
1.1  Background 
 
 
The fragile X syndrome is the most prevalent inherited form of mental
 
retardation in human. The prevalence of this disease is approximately 1/4000 for
 
males and 1/6000 for females in Western countries
1. In Indonesia the population of 
fragile X syndrome is approximately  2 % of the mental retardation population, and in 
Central Java thus far more than 50 patients have been identified 
2,3.  Causative 
location of fragile X syndrome is in fragile X mental retardation
 1 (FMR1) gene 
which is located on the long arm tip of X chromosome. The vast majority of 
mutations is an
 amplification of a trinucleotide (CGG) repeat in the 5' non-coding 
region
  of the FMR1 gene. Normal people have between 5 and 55 CGG
  repeats, 
carriers of the premutation have between 55 and 200 repeats,
  and full mutation 
subjects have more than 200 CGG repeats in their
  FMR1 gene
 4 . Full mutation 
expansion causes hypermethylation of the FMR1 promoter and expanded repeat itself 
resulting in no FMR1 protein (FMRP)
5. 
The absence of FMRP in the neurons is responsible for the observed mental 
retardation in fragile X patients. Recent studies suggest that fragile X syndrome is 
caused by exaggerated response upon signaling through group 1 metabotropic 
glutamate receptors (mGluR1 and mGluR5)
6. A basic mechanism underlying learning 
and memory is the ability of neurons to respond to signals by local translation of new  
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proteins at the connections between neurons (synapses), thus fine-tuning these 
connections. In a normal brain, increases in the rate of protein synthesis caused by 
synaptic activation of either mGluR1 or mGluR5 are balanced by FMRP (repressor). 
Since the fragile X patients lack  FMRP, target mRNAs of FMRP are translated 
massively.  
  Males carrying the full mutation are ussually cognitively affected, whereas 
females carrying a full mutation show mild to moderate mental impairment in only 
approximately 60% of cases. Females carrying a full mutation are characterised by 
cells with and without FMRP expression, which can be explained by the presence of 
two X-chromosomes and random inactivation of one of the X chromosome 
(Lyonisation). Thus, in cells without FMRP expression the normal FMR1 allele is 
inactivated, whereas in cells with FMRP expression the mutant FMR1  allele is 
inactivated. It has been suggested that an insufficient number of FMRP expressing 
neurons in the brain in affected females causes the learning deficits as a result of the 
proportion of mutant FMR1 alleles on the active X chromosome
7. 
  There are several methods to identify patients with fragile X syndrome. 
Molecular based diagnostics have been developed to obtain the reliable methods 
8. 
This DNA test allows the accurate determination of the length of the CGG repeat. 
PCR analysis can be used to amplify normal and premutation repeats, however it fails 
to amplify repeat sizes in the full mutation range. PCR-based diagnostics is also not 
suitable for the diagnosis of fragile X females as they are heterozygous and would be 
scored as normal, because of amplification of the normal-sized allele. Mozaic patients   
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with both premutation and full mutation alleles can also cause a false negative. 
Southern blot allows the accurate determination of the length of the CGG repeat. 
Methylation sensitive enzymes are used to determine whether the FMR1 gene 
consists of methylated or unmethylated normal, premutation, or full mutation alleles 
either in male or female patients. 
Willemsen and collegues, in 1995, have described alternative diagnostic tests 
to identify patients with fragile X syndrome on the basis of the absence of FMRP in 
lymphocytes and hair roots. This antibody test can identify persons with fragile X by 
means of only 1 or 2 drops of blood or 10-20 hair roots. Advantages of this antibody 
test, compared with the DNA test, include the following: (1) it can be performed in a 
single day and the costs are low; (2) it does not require radioactivity; and (3) it detects 
all loss-of-function mutations, including the prevalent CGG repeat amplification. 
Some males with fragile X show only a premutation FMR1  allele and not a full 
mutation on Southern blots 
9, In these cases the antibody test is often used to identify 
patients with a mosaic pattern (both premutation and full mutation present) because 
individual cells or hair roots can be scored for the presence of FMRP expression.  
The origin of hair roots from the ectoderm may explain why a better 
correlation exists between (the lack of) FMRP expression in hair roots from females 
carrying a full mutation and cognitive functioning compared to FMRP expression in 
lymphocytes 
10. Therefore, hair roots might be of value for predicting the mental 
capacities of females with a full mutation. It is likely that the X-inactivation pattern  
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within the ectoderm during early development will give rise to similar X-inactivation 
patterns in both brain and hair roots.  
Based on previous research, Semin area is one of sub district in Gunung Kidul 
which has large population of fragile X. It is interesting to carry on further study 
related the FMRP and cognitive functioning of the female fragile X full mutation. 
 
1.2  Research question 
 
 
Is there a relationship between FMRP expression in cell of hair roots and 
blood smears with cognitive functioning in female fragile X full mutation?. 
 
1.3  Objectives  
 
1.3.1 General 
These studies demonstrate a relationship between FMRP  expression in hair 
roots and blood smears with cognitive functioning in the female fragile X full 
mutation. 
1.3.2 Specific 
1.  To compare the magnitude of correlation between FMRP expression in 
hair roots and blood smears with cognitive functioning in the female 
fragile X full mutation.  






1.4  Benefits  
1.  To demonstrate diagnostic value of the antibody test for mental capacities 
in female carriers of the full mutation Fragile X. 
2.  To demonstrate the simply, rapid and inexpensive test for screening 
program of fragile X syndrome using non invasive materials from hair 
roots. 
 
1.5  Originality of the Research 
 
Researches Publications Year  Places  Result 
Willemsen 
R, et al 
Rapid antibody test for 




Netherlands  The diagnostic power 
of the antibody test in 
blood smear is good 
for males, whereas 
the results are less 
specific for females. 
Willemsen 
R et al 
Rapid antibody test for 
diagnosing fragile X 
syndrome: a validation of 
the technique. Hum Genet 
99:308–311 
(1997)  Netherlands  The diagnostic power 
of the antibody test in 
blood smear is good 
for males, whereas 
the results are less 
specific for females 
Tassone F et 
al 
FMRP expression as a 
potential prognostic 
indicator in fragile X 
syndrome, Am J Gen 
Genet, 84:250-261 
(1999) USA FMRP  expression 
may have potential as 
a prognostic indicator 
in males with fragile 




SMH et al 
A High rate of fragile X in 
a small district of 
Indonesia can be traced 
back to one common 
ancestor, The 8
th  
International fragile X 
conference, Chicago, July 
17-21 
(2002)  Indonesia  53% of the male and 
female fragile X 
patients in an 
institution of isolated 
village in central Java 
could be retraced to 
one ancestor. 
Willemsen 
R et al 
Predictive testing for 
cognitive functioning in 
female carriers of the 
fragile X syndrome using 
hair root analysis, Med 
Genet;40:377–379 
(2003)  Netherlands  FMRP test on hair 
roots might be strong 
prognostic indicator 
of cognitive 
functioning in female 
full mutation carriers 
and has great 























 Literature Review 
 
2.1    Introduction to The Fragile X Syndrome 
 
   Fragile X syndrome is the most common cause of mental retardation, after 
Down syndrome, worldwide. In 1943, Martin and Bell described the first extended 
kindred with mental retardation segregating in an X-linked manner. Fragile X is 
named after a site on the long arm of the X chromosome that is elongated and appears 
partly broken or ”fragile“ using cytogenetics analysis. The spectrum of fragile X 
syndromes ranges from normal development to developmental delay, mild to severe 
intellectual disabilities, autistic-like behaviour and attention problems.  
Prevalence of fragile X syndrome in the world is not precisely known. Turner 
and colleagues reported a prevalence of 1/4000-1/6000 for
 males in Western countries 
1. Based on the best available evidence, the National Fragile X Foundation indicates 
that approximately 1 in 3600 to 4000 males in the world are born with the full 
mutation for fragile X syndrome. Approximately 1 in 6000 females in the world is 
born with the full mutation for fragile X syndrome. Approximately 1 in 800 men in 
the world are carriers of the fragile X premutation and approximately 1 in 260 women 
in the world are carriers of the fragile X premutation.
11 Using several studies, 
Hagerman estimated that current frequency of full mutation females is ~ 1/2500 
12. In 
Taiwan it has been reported that in the screening program they found 1/1674 
premutation allele, whereas in Singapore, 2.4 % cases from screening of mentally  
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retarded people was found 
13,14. In Indonesia the population of fragile X syndrome is 
approximately about 2 % from the total mental retardation population, and in Central 
Java so far more than 50 patients have been identified 
2,3. In the same study 53 % 
males and females with fragile X in institution of an isolated village in Central Java 
could be traced to have one ancestor
 15.  Another study in a special school for 
mentally retarded individuals, revealed 3,9% from the total MR population 
16.  
Dysmorphic features are variable in both males and females and are not always 
present. The classic features include elongated face with prominent jaw, which are 
more obvious after puberty, prominent and large ears, high arched palate, large 
testicles, which are mainly seen after puberty, recurrent ear infections, flat feet, loose 
joint, congenital hip dislocation, scoliosis, strabismus, and seizures 
17. 
Affected individuals may show psychiatric disorders, including attention 
deficits hyperactivity disorders (ADHD), autistic features 
18 such as gaze avoidance 
(poor eye contact), shyness, hyperactivity, hand flapping, hand biting, and tactile 
defensiveness. Neurologic abnormalities that are occasionally seen include 
strabismus, nystagmus, and epilepsy. Seizure may be seen in ~ 17 % fragile X males 
based on electrophysiology data 
17 
The clinical phenotype is highly variable which may reflect variable expression 
of the mutation (mosaic pattern). The hallmark of the fragile X phenotype is mental 
retardation. Males with a full mutation are always mentally retarded and may show 
typical physical and behavioural features. Females with fragile X are usually less 
severely affected than males, probably as a result of X inactivation. There are no  
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obvious physical characteristics of females with fragile X, and likewise mental 
impairment and behavioural problems are usually milder. Sixty percent of females 
carrying a full mutation have cognitive impairment varying from mild to borderline 
17,19. 
Premutation male and female carriers usually have no physical  features and 
negative cytogenetics analysis, however ,  20% of female PM
  carriers manifest 
premature ovarian failure (POF) defined by
  menopause before 40 years. POF 
represents the final stage of
 a variety of diseases that result in the loss of ovarian 
follicles 
20. Older males carrying a PM (ranging
 between 71 and 135 CGGs, to date), 
may exhibit an unique neurodegenerative
  syndrome characterized by progressive 
intention tremor and  ataxia named
  fragile X-associated tremor/ataxia syndrome 
(FXTAS). More advanced cases may be accompanied by memory
  and executive 
function deficits, anxiety, Parkinsonism, peripheral




2.2     FMR1 gene mutations mechanism 
 
 
In the vast majority of cases fragile X syndrome is caused by an unique form 
of dynamic mutation due to a stretch of CGG repeats in the 5’ non coding region of 
the FMR1 gene. This trinucleotide repeat is highly polymorphic and the expansion 
may occur as a multi-step process over many generations 
4.  
There are four class of alleles observed in the FMR1 gene, according to the 
length of CGG repeat.  The first group contains alleles ranging between 5 and 40  
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CGG repeat units. Repeats of this size remain stable upon transmission. A second 
class of alleles, largely overlapping with wild-type in size, show 40-55 CGG repeats  
and are called “gray zone alleles” or protomutations. Protomutations are only slightly 
unstable over many generations and never expand to a full mutation. They are 
transmitted silently across generations, sometimes adding (or subtracting) just a few 
repeats in length and creating a ‘pool’ of at risk alleles in the population that 
eventually can become premutation. The third class is called premutation. It may 
become unstable upon maternal transmission to the next generations, and can increase 
or decrease in length upon transmission to the next generations.
 The fourth class is 
called full mutation (>200 CGG) that usually leads to hypermethylation of both the 
promoter region and CGG repeats of the FMR1 gene. The gene is transcriptionally 
silenced, and consequently, FMR1 Protein (FMRP) is absent 
22 
Alleles ranging between 55 and 200 CGG repeats are classified as 
premutations. Carriers with premutations alleles were usually considered of having 
normal gene function, including normal FMR1 mRNA and FMRP levels, and normal 
cognitive abilities 
23. However, a number of reports have shown physical and 
psychological problems in males and females carrying premutations 
17, 24. 
Interestingly, carriers of a premutation show a consistent increase of FMR1 mRNA 
levels (2-8 fold), despite reductions in FMRP levels, in their lymphocytes 
25. 
Expansion to a full mutation (over 200 CGG repeats) usually leads to an 
absence of FMR1 Protein (FMRP). In males, the methylated full mutation is always 
associated with mental retardation, whereas approximately 60% of females with a full  
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mutation have only mild mental impairment. In females the situation is more complex 
because their cells contain two X-chromosomes. Dosage compensation in somatic 
cells of females is necessary for the expression of equal amounts of X-linked genes, 
which is achieved by inactivation of one of two X-chromosomes. The process of X-
inactivation during embryonic development occurs shortly after blastocyst 
implantation 
26. Once X-inactivation is established, it is maintained during further cell 
proliferation and differentiation of the embryo. The choice of which X-chromosome 
is inactivated is a random process. Studies on monozygotic twins support this fact. At 
2000, Willemsen and colleagues have reported about monozygotic twin sisters, who 
have a different phenotypic pattern (normal and learning disabilities). Both of them 
are full-mutation, based on DNA analysis, but one sister has normal FMRP 
expression and normal cognitive functioning, whereas the other sister show a lack of 
FMRP expression and presented with learning disabilities. It has been concluded that 
timing of X-inactivation process occurs earlier in development than inactivation of 
the full-mutation allele 
27.  
 
2.3    Mechanism of CGG repeat expansion 
 
 
The exact mechanisms causing repeat instability is not clearly understood. All 
short tandem repeat undergo small changes over generations. These changes involve 
one or two repeat units and result in what is called a “polymorphism”. These 
variabilities are observed within the normal alleles. Premutations show more 
instability than other polymorphisms. Contractions and expansion involving 10-20  
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triplets occur quite frequently. Once a certain threshold is passed, the repeats behave 
very unstable, resulting predominantly in large expansion. In females carrying 
expanded CGG repeats, their length increases
  over generations. Once beyond a 
specific threshold the repeat
 becomes dramatically unstable, expanding rapidly up to 
a few
  thousand triplets. This phenomenon has given rise to the term
  ‘dynamic 
mutation’ 
28. 
The mechanisms which have been proposed to
 play a role in repeat instability 
involve meiosis as well as
 DNA replication, recombination and repair. During all 
these
 processes, duplication of the DNA occurs, allowing an opportunity
 for DNA 
mutations and secondary structures like hairpins or
 tetraplex to form, errors which 
must be removed by proof-reading
 and repair processes. These processes, which aim 
to keep mistakes
 in the copying of DNA to a minimum, are balanced by processes
 in 
meiosis such as recombination which generate maximum genetic
  variation for a 
species 
29. 
 The presence of cryptic AGG interruptions within the CGG repeat led to 
suggestion that these interruptions might provide stability to the repeat and that 
instability might result from loss of AGG interruptions. Analysis of the AGG repeat 
interruptions showed that in most common normal alleles, AGG interruptions are 
found downstream of 9 or 10 CGG triplets. In longer repeat, relatively fewer AGG 
interruptions are found. Loss of these AGG interruptions always occurs at the 3’ end 
of the repeat tract. The longest pure CGG tract found within a premutation or full  
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mutation is always located at the most 3’ end. It is believed that a pure CGG tract at 
the 3’ end of more than 38 repeats is enough to cause instability 
30. 
Another theory for the instability is focused about formation of d(CGG) 
secondary structures. Several structures of the CGG repeat, such as hairpins and 
tetrahelical structures have been suggested. The stability of the different structures 
seems to differ between both templates. Pausing of DNA polymerase at both hairpin 
and tetrahelical structures has been observed both in vitro and in vivo 
31,32. This 
stalling of the action of DNA polymerase might increase the probability of DNA 
polymerase slippage. According to the slippage model, this may result in expansion 
of the CGG repeat. 
  
2.4    Timing of the CGG repeat expansion 
 
 
   Timing of the CGG repeat expansion is not known clearly;
 two time periods 
have been suggested to be implicated, that is, meiosis and early embryonic 
development.
 The anticipation in each succeeding generation of fragile X
 families 
indicates that expansion must occur in germ cells (either
 during premeiotic or meiotic 
division). Malter and colleagues have shown that a full mutation is present in oocytes 
from a female foetus with a full mutation. There is strong, albeit indirect, evidence 
against a postzygotic transition to a full mutation 
33. 
 A kind of selection against full mutations is proposed for the male germ line. In 
mature sperm cells no FMRP is found, whereas in primordial germ cells there is clear 
expression of FMRP. Immunohistochemistry of the testes of full mutation foetuses  
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showed only a few primordial germ cells during early development that produces 
FMRP, which suggests the presence of a premutation in these FMRP-positive cells. 
During later development, the number of primordial germ cells expressing FMRP in 
full mutation male foetuses increases.  This suggests that a selection process is 
present during embryonic spermatogenesis 
33.  
 
2.5    Fragile X Mental Retardation Protein (FMRP)  
 
 
FMRP is the gene product of the FMR1 gene on chromosome Xq 27.3, termed 
FraX A. The FMR1 gene contains 17 exons spanning 38 kb. Splice donors and 
acceptors located in the 5’ portion of the gene demonstrated greater adherence to 
consensus than those in the 3’ end, providing a possible explanation for alternative 
splicing in the FMR1 gene. The gene, expressed as a 4,8 kb mRNA, which translates 
into a 614 aa polypeptide of 69kDa 
34. FMRP expression is widespread throughout 
the body, however it has been associated with abundant expression in neurons and 
with testicular expression in spermatogonia 
35.  
FMRP contains RNA-binding sequence motifs, including two KH domains 
and an RGG box. The precise physiological function of FMRP is still not defined; 
however, a role in transport and/or translational efficiency of mRNAs has been 
suggested elsewhere 
36. Recently, a subset of mRNAs containing a G quartet has been 
identified as a potential target for FMRP, including those for important neuronal 
proteins like microtubule-associated protein MAP1B and semaphorin 
37. It has been 
suggested that the absence of FMRP in neurons results in misregulation or  
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mistrafficking of a subset of mRNAs and that this is the basis of the mental 
retardation in fragile X patients. 
Recent evidence shows that mRNA transport translation in dendrites plays an 
important role in neuronal processes, including synaptic plasticity, which is essential 
for memory storage and learning processes 
38. Local protein synthesis at the synapse 
may be an important aspect of proper synaptogenesis because most dendritic 
polyribosomes are located within or at the base of spines. The presence of the protein 
machinery, postsynaptically, allows neurons to rapidly respond to signals at particular 
synapses through local translation of (specific) mRNAs. For this purpose, efficient 
transport of specific mRNAs, via mRNP particles, has to be established to this 
cellular location followed by efficient translation of mRNAs in the vicinity of the 
synapse. The dynamics of the transport of mRNP particles in neurons have been 
studied by different experimental approaches, and a supramolecular complex 
containing mRNAs, translational factors, and ribosomal subunits and motorproteins 
has been identified 
39.  
Recent studies suggest that fragile X syndrome is caused by exaggerated 
signaling through group 1 metabotropic glutamate receptors (mGluR1 and mGluR5) 
6. A basic mechanism underlying learning and memory is the ability of neurons to 
respond to signals by creating new proteins at the connections between neurons 
(synapses), thus fine-tuning these connections. In a normal brain, synaptic activation 
of mGluR5 is balanced by FMRP, similar to the way the accelerator and brake  
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balance the speed of a car. However, fragile X patients lack  FMRP, leading to 
excessive protein synthesis at the synapse. 
 
2.6    Cognitive functioning and Mental Retardation 
 
 
Cognitive function refers to a range of high-level brain functions, including 
the ability to learn and remember information: organize, plan, and problem-solve; 
focus, maintain, and shift attention as necessary; understand and use language; 
accurately perceive the environment, and perform calculations. There are many 
factors that involve in development of cognitive functioning including genetics, 
health status either prenatal, antenatal, or postnatal, chronic disease, nutrition, level of 
education, social interaction, and many others factors. Cognitive functioning usually 
is represented by degree of intellectual quotient (IQ) or ranking of a person's mental 
abilities.
40 
Cognitive functioning itself was proposed that it is based on the general 
intelligence factor (abbreviated g), terms used in the field of psychology to quantify 
what is common to the scores of all intelligence tests. The two main components of 
general cognitive ability (g) were those identified by Spearman in 1923 
41 are 
respectively: (a) eductive ability (from the Latin educere, meaning ‘‘to draw out’’), 
the ability to make meaning out of confusion, the ability to generate high-level, 
usually nonverbal, schemata which make it easy to handle complexity; and (b) 
reproductive ability—the ability to absorb, recall, and reproduce information that has 
been made explicit and communicated from one person to another.   
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Cognitive disability that commonly termed as mental retardation (MR) is 
defined as significant subavarage intellectual function existing concurrently with 
deficits in adaptive behavior and manifested during the developmental period 
42. 
Etiology of mental retardation can be caused by many factors such as genetic, 
environmental and ecogenetic factors. The diagnostics process is considerably if the 
timing of development insult can be determined: prenatal, perinatal, and postnatal. 
 




   Diagnostic categories                                                                                   % 
Chromosomal abnormalities                                                                          4 -28 
Recognizable of syndromes                                                                           3 - 9 
Nervous system abnormality                                                                         3 - 17 
Complications of prematurity                                                                        2 - 10 
Perinatal condition                                                                                         8 - 13 
Environmental/ teratogenic conditions                                                          5 - 13 
Metabolic/endocrine causes                                                                           1 - 5 
Unknown                                                                                                       30 - 50
 
Mental retardation is usually referred by two conditions both of a person's 
level of intelligence measured by Intelligence Quotient (IQ) test and adaptive skills. 
The term "adaptive skills" means how well a person can deal with the tasks of 
everyday life. These tasks include the ability to speak and understand; home-living 
skills; use of community resources; leisure, self-care, and social skills; self-direction; 
basic academic skills (reading, writing, and arithmetic); and work skills
 43. 
Classification of the degree of Intelligence quotient (IQ) from mental-health  
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professionals has been used in different area. Table 2 and 3 below depict on both 
educational and psychiatry utility. 
 









Very Superior  130 and above 2.2  2.1 
Superior 120-129  6.7  8.3 
High Average  110-119  16.1  16.1 
Average 90-109  50.0  50.3 
Low Average  80-89  16.1  14.8 
Borderline 70-79  6.7  6.5 
Extremely Low  69 and below  2.2  1.9 
                               Table 3. IQ Classifications in Psychiatric Use 
45 
Classification  IQ Score 
Borderline Intellectual Functioning  IQ 71-84 
Mild Mental Retardation  IQ 50-55 to approximately 70 
Moderate Retardation   IQ 35-40 to 50-55 
Severe Mental Retardation  IQ 20-25 to 35-40 
Profound Mental Retardation  IQ below 20 or 25 
 
 
2.7    Mental Retardation and FMRP 
 
 
The molecular basis of the phenotypic variability in both males and females of 
fragile X patients is believed to be linked to the variable number of neurons in the 
brain that express FMRP. In males a methylated full mutation in their cells will 
always lead to mental retardation; however 13% of males with fragile X syndrome 
are high functioning with an Intelligence Quotient (IQ) score>70 
46. Most high  
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functioning males show either partial methylation of the full mutation or a variable 
combination of premutation and full mutation alleles 
47,48. In contrast, approximately 
60% of the full mutation females show cognitive deficits. The spectrum of 
phenotypic involvement varies from mental retardation to mild learning disabilities 
and/or emotional difficulties without notable physical involvement 
17,19. 
FMRP has been hypothesized as an RNA binding protein that is involved in 
the regulation of translation of many other transcripts in neurons 
49. Lack of FMRP in 
fragile X patients causes disregulation of the FMRP target transcripts. FMRP 
typically acts as a translation suppressor that is involved in synaptic plasticity through 
regulating local protein synthesis of specific target mRNAs in response to synaptic 
stimulation. FMRP binds to transcripts either in the cell soma or in the nucleus and 
subsequently these transcripts are transported to the synapse using a kinesin 
motorprotein
50. After stimulation of the metabotropic glutamate system, FMRP 
mediates the translation of important transcripts for synaptic structural changes or 
synaptic plasticity 
50,51. 
One of the important pathways for cognitive development is the metabotropic 
glutamate receptor 5 (mGluR5) pathway (a member of group 1 metabotropic 
glutamate receptors) which leads to long term depression (LTD), weakened synaptic 
connections and eventually synaptic elimination. LTD is important in normal brain 
development so that unstimulated synaptic connections can be eliminated. Through 
long term potentiation (LTP) other synaptic connections are made stronger with 
stimulation. The mGluR5 pathway requires protein synthesis and FMRP normally  
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regulates this protein synthesis. However, in the absence of FMRP, like in fragile X 
syndrome, LTD is dramatically enhanced leading to more weak, immature and 
elongated synaptic connections 
6. 
A number of clinical features including epilepsy, MR, hypersensitivity to 
tactile stimuli, social deficits, and even loose stools have been hypothesized to be 
related to enhanced mGluR5 activity and LTD in fragile X syndrome. This is 
important for clinicians to understand because these findings have direct therapeutic 
implications. Both mGluR5 antagonists and ampakines that stimulate the AMPA 
receptors are in clinical trial stages of development and they have the potential to be 
successful in specific treatments for fragile X syndrome in the future. 
 
2.8    Diagnosis of Fragile X syndrome 
 
 
Methods to identify patients with fragile X syndrome have been rapidly 
developed. Cytogenetic methods which identified the fragile site at the long arm of 
the X-chromosome using specific media are not reliable as a diagnostic tool. 
Cytogenetic analyses show higher false positive rates due to expression of other 
fragile sites close to fragile X syndrome locus. False negative results can also occur 
due to repeat length, an age related decreased or technical issues 
52.  
DNA tests allow the accurate determination of the length of the CGG repeat 
8. 
PCR analysis can be used to amplify normal and premutation repeat, however, it fails 
to amplify full mutation repeats. PCR is also not suitable for the diagnosis of fragile 
X females as they are heterozygous and would therefore be scored as normal because  
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their notrmal allele will be amplified preferentially. Mozaic patients with normal or 
premutation alleles can also cause false negative results. Southern blot hybridization 
combined with methylation sensitive enzyme can be performed to determine whether 
the gene contains methylated or unmethylated alelles, either normal, premutation, or 
full mutation. Alternative diagnostic test for screening using immunohistochemistry 
method can also be performed to identify patients with fragile X syndrome on the 
basis of the absence of FMRP in lymphocytes and hair roots 
9,10 
 
2.9    FMRP Investigation 
 
 
It has been shown that high FMRP expression is present in the brain and 
testes. Low FMRP expression is present in blood cells; however FMRP can be 
detected in lymphocytes using specific enhancement steps in the 
immunocytochemical procedure. Willemsen and colleagues have described an 
alternative diagnostic test to identify patients with fragile X syndrome on the basis of 
the absence of FMRP in lymphocytes in fragile X patients. This antibody test can 
identify persons with fragile X by means of only 1 or 2 drops of blood 
9,53. 
Advantages of this antibody test, compared with the DNA test, include the 
following: (1) it can be performed in a single day; (2) it does not require 
radioactivity; and (3) it detects all loss-of-function mutations, including the prevalent 
CGG repeat amplification and other mutations. Nevertheless, a minority of fragile X 
patients still escape detection by DNA tests. Some males with fragile X show only a 
premutation allele and not a full mutation using Southern blot analysis. In this cases,  
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the antibody test is more reliable. The pictures of FMRP expresssion in hair roots is 










Testing hair roots allows the opportunity of testing a different tissue. 
Lymphocytes originate from connective tissue, which arises from the mesoderm 
germlayer. In contrast, both neurons and skin develop from the ectoderm. Most hair 
roots in affected males are devoid of FMRP. In cells from female full mutation 
carriers, one of the two X-chromosomes is inactivated and will not produce FMRP. 
As human hair roots are of clonal origin, they are labelled either positive or totally 
negative for FMRP expression, depending on which X-chromosome is active, the 
normal FMR1 allele or the mutant FMR1 allele. It has been suggested that hair root 
testing might be of value for predicting the mental functioning in female carriers of 
the full mutation, because like brain tissue, hair roots originate from the ectoderm 
during embryonic development. Thus, the X-inactivation pattern in hair roots might 
Figures 1. The difference of FMRP expression in cell of hair root follicle between 
blonde hairs and pigmented hairs. 
  Red appearance reflecting FMRP expression in the bulb of blonde hairs 
is more clearly visible than in pigmented hair follicles (arrow).   
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be indicative of the X inactivation pattern in the brain and in this way reflects the 
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2.12. Hypothesis   
 
 
1.  There is relationship between FMRP expression in hair roots and 
cognitive functioning in female carriers of the full mutation. 
2.   There is difference of correlation between FMRP expression in hair roots 
and blood smears with cognitive functioning in female carriers of the full 
mutation. 
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3.1    Design 
 
  This research was conducted as cross sectional analysis. 
3.2    Places and time  
 
  This research was conducted in three places as follow:  
1.  Semin village (Indonesia) as place of collecting samples 
2.  CEBIOR, Medical Faculty of Diponegoro University Semarang for DNA 
extraction and hair roots immuno-incubation/examination. 
3.   MGC Dept of Clinical Genetics, Erasmus University Rotterdam, The 
Netherlands as preservation study of hair roots, Southern blotting and 
blood smears examination. Period of research is from September 2007 
until August 2008.   
 
3.3   Subjects 
 
3.3.1.  Population 
 
Population of this study is females from the fragile X family either 
affected or not affected. 
3.3.2.  Achievable population 
 
Females of the fragile X family either affected or not affected in the 
District of Semin, Gunung Kidul regency, Yogyakarta, based on 
previous study 
15 and one family in Purwokerto.  
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3.3.3.  Females sample 
 
We collected samples with the following criteria: 
    Inclusion:   1.   Age range: 4 – 70 years old. 
               2.   Agree to follow the research 
  Exclusion:  1.   Malformation appearances 
 2.   Down syndrome appearance 
                                           3.   Refuse to follow the research  
    We then used total sampling method to include in this research. 
 
3.4  Collecting materials. 
 
After having informed consent we collected the venous blood and hair roots 
form   the probands with the following: 
1.  Ten ml bloods were drawn and smears were immediately made from fresh 
blood. The remaining blood subsequently stored in the EDTA tubes for 
DNA extraction in the laboratory.  
2.  Hair roots were plucked smoothly from different area behind the ears 
using hands or specials pincet. It is due to better representative of limbic 
system and hippocampus area of the brain
40. Hair roots then were placed 
in envelops with the name and code of patients. 
 
3.5  Variable and Operational Definition 
 
3.5.1   Variable definition. 
1.   FMRP: protein produced by FMR1 gene on chromosome Xq27.3.  
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2.  Cognitive functioning: basal intellectual function, which affects 
ability to think, reason, and learn. 
3.   Female fragile X full mutation: a condition that the 5’ UTR region 
of FMR1 gene of a female has over 200 CGG repeat expansions. 
3.5.2.   Operational definition 
1. FMRP expression: percentage of positive-stained hair roots and 
blood smears using antibody test against FMRP. Blood smears and 
at least 20 hair roots were examined with Willemsen analysis 
procedure and counted by three different investigators who were 
unaware with the name of probands and the others result counting. 
Total counting from three different investigators was divided to get 
final value. Data is continuing scale.  
2.  Cognitive functioning: non-verbal Raven 
54 test was applied to 
calculate IQ equivalent. Raven is International standard test to 
measure IQ equivalent, based on non-verbal intervention. Data is 
continuing scale. 
3. Female fragile X full mutation: Southern blot analysis was 
implicated to determine genotypes of probands. This technique 
used a methylation sensitive enzyme (Hind III and Eag I) that 
allows us to discriminate between methylated and unmethylated 
FMR1 alleles. Digoxigenine labelled probe pP2  and  radioactive  
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labelled probe pAO365 were performed to show the genotypes of 
probands. Data is categorical scale.   
 
3.6    Research Plot 
     
  
 
     
   
 
   





 3.7    Measurement Technique  
  3.7.1      General: 
All persons have given written informed consent. After giving informed 
consent, individuals were visited at home or in school to measure cognitive 
functioning using Raven's Progressive Matrices. After completing the raven 
test, 10 ml heparinized peripheral blood was drawn from all subjects and 
subsequently bloodsmears were immediately made. After that, approximately 
Sampling selection 
Females from 
fragile X family 
Cognitive functioning 
measurement 
FMRP test in hair 
roots and blood smear 
Southern blot 
Data analysis and 
research report  
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20 hair roots were plucked from different areas behind the ear on the scalp. 
Hair with visible bulbs and sheaths were selected and trimmed to just above 
the sheath. The hairs which were examined in Rotterdam were shipped 
directly after plucking. The hairs which were examined in Semarang were 
stored at room temperature after plucking day for next day experiment. 
 
3.7.2    Preliminary study. 
Preservation test for hair roots was done in Roterdam to test how long the hair 
roots can be stored at room temperature. Two series (periods) of hairs were 
completed from three different persons. The cut –off point was 75 % based on 
earlier report in literature 
7 . Willemsen method was used to execute this test. 
 
3.7.3     FMRP expression in Hair root. 
Hair roots were fixed in 3% paraformaldehyde at room temperature (RT) for 
10 min. Cells were permeabilized by treatment with 100% methanol at RT for 
20 min. Hair roots were washed with phosphate-buffered saline, containing 
0.15% glycine and 0.5% bovine serum albumin, and incubated as whole 
mount with mouse monoclonal antibodies against FMRP at 4 C degree for 
overnight. Visualization of antibody-antigen complexes was achieved by an 
indirect alkaline phosphatase technique, using    m-Powervision poly AP for 
1 hr, followed by incubation in new fuchsin substrate–chromogen system 
(DAKO) for 10-15min. Levamisole was added in the substrate solution,  
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according to the guidelines of the manufacturer, to block endogenous alkaline 
phosphatase activity. Immunolabeled hair roots were examined with a stereo 
zoom microscope at a final magnification of 70 x. The number of FMRP-
positive hair roots showing red color was expressed as a percentage of the 
total number of hair roots examined. Three investigators who were unaware of 
the phenotype of the individuals randomly numbered and scored all the hair 
roots for the presence or absence of FMRP. The mean of counting was used as 
a final data. 
  
3.7.4       FMRP expression in  blood smears  
Blood smears were fixed in the 3% paraformaldehyde for 10 minutes 
followed by a permeabilization treatment with 100 % methanol for 20 minutes 
at RT. After washing in PBS– for 5 minutes, the endogenous peroxidase 
activity was blocked with PBS-Blocked (100 ml 0.1M PBS, 2 ml 30% H2O2, 
1 ml 12.5% sodiumazide) for 30 minutes.  Smears were washed in PBS+ 
containing 0,5 % BSA and 0,15 % glycin and incubated with mouse 
monoclonal antibody against FMRP at 4
o C for over night. Smears were rinsed 
in PBS+ for 3x5 minutes followed by biotinylated secondary antibody 
treatment for 10 minutes (Zymed-Kit “Reagent B). Subsequently, an 
incubation with peroxidase conjugated streptavidin for 10 minutes was 
performed after rinsed in PBS+ for 3x5 minutes. Finally, smears were rinsed 
in PBS+ for 4x5 minutes and PBS– for 5 minutes, respectively. As final step,  
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smears were incubated with DAB substrate (DAKO liquid DAB substrate-
chromogen system) for 2x20 minutes and 1x10 minutes followed by Nuclear 
fast Red as counterstaining. A serial dehydration in ethanol and xylen is 
performed before mounted with Entellan. Smears were dryed for overnight at 
37
o in an incubator. Immunolabeled smears were examined using a   
lightmicroscope at final magnification 1000 x. The brown precipitate in the 
cytoplasm of lymphocytes illustrated positive FMRP expression. The 
percentage of FMRP expression was achieved by counting  hundred 
lymphocytes in different areas and scored them for FMRP expression. 
 
3.7.5       Salt Saturation Method for DNA extraction  
55 
  EDTA frozen blood was mixed with 5-10 ml NH4Cl lysis buffer for 10-30 
minutes at RT. Solution was centrifuged for 5 minutes at 3000-3500 RPM and 
supernatant was discharged.   NH4Cl lysis buffer was added followed by 
centrifugation for three times. White pellet was resuspended in 2 ml TE lysis 
buffer, Proteinase-K and 100 ul 10% SDS and incubated at 50
oC for 24 hours. 
Suspension was added with NaCl 6M approximately one third volume and 
centrifuged at 4000 RPM for 10 minutes. A new tube was used for 
supernatant and mixed with 100% ethanol twice the volume of the 
supernatant. DNA was washed with 70% ethanol, dried  and subsequently 
blended with TE buffer.  
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      3.7.6        Southern Bloot Analysis using digoxigenine labelled probe pP2 
  Seven mg of the genomic DNA (35ul of 200 ng/ul) was mixed well with 4.75 
ul aquadest, 5 ul 10x SuRe/Cut Buffer H (Roche), 3 ul 50 mM spermidine, 
1.25 ul Hind III which has recognition site AAGCTT (Roche cat 
#10656313001), 1 ul Eag I which has recognition site CGGCCG (Biolabs cat 
# R0505L). The mix was incubated for overnight at 37 
0 C to complete 
digestion. Five ul 10x Ficoll loading buffer was added to 45 ul of each 
digestion product and   electrophoresed on a 0.7% agarose gel for overnight at 
45 V. DNA was transferred to a nylon membrane (Hybond N1, Amersham) in 
Southern blotting apparatus for overnight followed by baking the membrane 
20 minutes at 120 C. Prehybridization was performed in roller bottle with pre-
heated DIG Easy Hyb Hybridization solution (Roche Cat # 11603558001) at 
least 1 hour at 42 C, 10 RPM. Prehybridization solution was replaced with 
hybridization solution contained denatured digoxigenine labelled probe pP2 
(courtesy from Prof Ben Oostra, ErasmusMC, probe sequences and location 
of pP2 probe were noted in below) and leaved at 42 C overnight to complete 
hybridization. Membrane was washed 2x5 minutes with 50 ml 2xSSC/0.1 % 
SDS at room temperature. Detection procedure was achieved in clean trays 
with the following procedure; equilibrated membrane in 100ml washing 
buffer for 5 minutes followed by incubation in blocking solution for 60 
minutes. Membrane was put in a piece of SaranWrap. 10 ul Anti-
digoxigenine-AP-conjugate was added into blocking solution and membrane  
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was incubated in this solution for 30 minutes. After incubation, antibody 
solution was discarded and the membrane was washed in washing buffer for 
2x15 minutes and detection buffer for 5 minutes. In the meantime 15 CDP star 
solutions (Roche Cat. no. 1685627) were diluted in 1500ul detection buffer. 
After washing procedure, membrane was placed in two sheets of cuted plastic 
bag and CDP star solution was pipette on top of the membrane. Bubbles 
present under the sheet were removed and membrane was incubated for 5 
minutes. After incubation, liquid excess was removed and plastic bag was 
sealed. Membrane was exposured in film from 10 and 30 minutes. A normal 
band was shown by the presence of a 2,8 kb band illustrating normal X 
chromosome and 5,2 kb band reflecting methylated X chromosome. 
 
































tgcgtagaatcgttcacggtcctagattagtggt    
 
  3.8.7    Southern Bloot Analysis using Radioactive labelled probe pAO365 
Seven ug DNA (in 35 uL diluted solution with milliQ) was digested with 
restriction endonuclease enzyme (1,25 uL Hind III and 1,5 uL Eag I) in the 
buffer React H together with 20 mM Spermidine in a total volume of 15,75 
uL for a minimum 5 hours at 37C.  
Five uL loading buffer (bromophenol blue) was added to Digested DNA and 
subsequently 50 uL was loaded per lane. Thirty uL of 0,5% ethydium bromide  
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was added to the agarose gel. Electrophoresis of DNA was performed 
overnight in a 0,8% agarose gel at 38 volt in TAE buffer.  
DNA in agarose gel was transferred into nylon membrane (Genescreen Plus 
Perkin Elmer) using a 0,4N NaOH+NaCl buffer solution for capillary blotting 
using filter membrane, paper stack and weighing mass (~ 500 grams) above 
the membrane for five hours. Then, the nylon membrane was washed in the 
phosphate buffer, dried and cross-linked into a 1200 UV Stratalinker.  
Labelling beads were prepared by adding a tube Ready-To-Go DNA labelling 
beads (-dCTP) (Amersham) to 20 uL of water and incubating this solution for 
5-60 minutes on ice. In the meanwhile the probe mix (pAO365) (sequence 
probe: ctcgagcgcccgcagcccacc. Position was indicated below ) was 
denaturated at 95C for 5 minutes. Thereafter the Probe-mix was mixed with 
the labelling beads and 2,5 uL (alpha-32-P-dCTP) was added for incubation 
overnight. A sephadex G-50 column was used to purify the labelled probe. 
Oligonucleotide labeling products were denatured at 95 C for 5 minutes. The 
oligonucleotide labeling products were added to a hybridization buffer. 
Hybridization was performed overnight at 65 C. Tough cleaning was 
performed in 0,1 % SDS + phosphate buffer twice at 65C for 5 minutes and 
once at 65 C for 20 minutes. And finally only phosphate buffer was used to 
end the washing procedures.  
Autoradiography was performed on X-ray film (Kodak ECL) for 1-3 days at -
80 C using intensifications screens.  
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3.8   Analysis of the data   
All data was checked and determined correctly. Data then was coded, 
tabulated, and entered into the computer. Data was analyzed into description 
and hypothetical analysis. Before carrying out the hypothetical analysis, first 
the normality of the data was determined by Kolmogorov Smirnov test. 
Pearson correlation analysis was used at  α = 0,05 using SPSS 16 for 
Windows to determine significant correlation. 
 
3.10.  Research ethic 
This research has been approved by Committee of Ethic, Faculty of Medicine 
Diponegoro University. The ethical clearance contains the statement that this 
research was conducted by the researcher with paying attention to Helsinki 
Consensus 1975 and PNEPK department of health of Indonesia. Informed 
consent explaining about the research, procedure, and benefits of the research 
was provided to all the subjects. It was also informed that any identities of the 






4.1.     Characteristic of probands 
 
       Thirty patients from a known fragile X family and three non fragile X 
syndrome based on previous research were included in this research. Most of them 
have been included in several previous researches. The characteristics of the probands 
are depicted in table 5, table 6, and table 7. 
 
         Table 4. The age distribution of the probands 












9.09   
 
Most of probands are in age range of 35-65 with 48.48 % and the lowest are in range 
<16; 9.09 %. Most of female patients of fragile X in this area are above 20 years old.  
 
    Table 5. The occupation distribution of the probands 
















  Occupational background of the probands is dominated as farmer labors, a non 
informal service, whereas traditional trader occupies the lowest endeavor. Seven 
students who are now studying, 6 of them were doing their study in special school 
(SLB) and 1 of them is in high school level (SMU), whereas non student status has a 
varying degree in educational background (table 6). 
 
        Table 6. The educational background of the probands 
  Education  number        percentages 














18.18%     
 
Approximately, 61 % of probands are not educated and only about 6 % of probands 
who reach the high school level.  
  In general, physical health of the probands was in good condition. However, 
we could not report physical examination of the probands in whole context as we did 
not concern in physical features. All probands looked like displaying low nutritional 
status. It was figured by status of Body Mass Index (BMI) of the probands that 87 % 
of them showed underweight range. Most of them have lack in daily hygiene living 
such as self care and feeding. They were accustomed to be not quite aware to their 






4.2.     Preliminary study.  
Preservation of hair roots was performed before testing to the hairs from 
subjects. It would be valuable to know how long the hairs can be stored at room 
temperature. Test was applied using hair roots from normal individuals (man and 
woman). Two series (periods) of hairs were tested from three different persons. For 
each incubation, experiment was using a mixture of hair roots from these persons. 
 
       Figure 3.   Diagram of period and percentages of hair roots expressing FMRP 
that was stored at room temperature (RT). 
The color lines indicate the series and horizontal line indicate cut 
of point. 
 
Figure 3 illustrated that the hairs can be stored at room temperature for 14 
days before they reach the cut-off point (75 %). In our planning, this would allow us 
to pluck the hairs in Indonesia and ship them to Rotterdam because transport should 
take only one week.   
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In the first experiment, hair samples from Indonesia which were shipped by 
courier mail were tested for immunohistochemistry. The analysis was performed in a 
blind fashion and the hairs from normal persons were also included among these 
samples. The result was drawn in the table below: 
      Table 7 .    Distribution of FMRP expression in hair roots 
that were examined in  Rotterdam for preliminary study 
 
Number  Code  % FMRP in hair roots 
1 SM030  76 
2 SM015  76 
3 SM016  60 
4 SM020  54 
5 SM022  72 
6 SM008  56 
7 SM007  91 
8 SM009  81 
9 SM002  51 
10 SM023  20 
11 SM013  54 
12 SM021  85 
13 SM019  68 
14 SM028  86 
15 SM024  84 
16 SM029  36 
17 Normal  1  74 
18 Normal  2  70 
19 Normal  3  90 
         
We found that FMRP expression from these samples ranges between 20 % 
and 91 %. However, two normal samples that were included in this examination 
showed low expression below the cut-off point of 75 %. Since the normal persons 
expressed too low percentages of FMRP, we then decided to perform the hair roots 
test in Indonesia.   
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4.3.   FMRP Expression of the subjects. 
In Indonesia we added three mentally retarded persons as comparator from 
non-fragile X syndrome to know whether FMRP also influence their cognitive 
functioning. In addition, the blood smears that were freshly made in Indonesia 
shipped to Rotterdam to perform immunohistochemistry test. Fragile X Mental 
Retardation Protein (FMRP) expression was shown in both blood smears and hair 























C  D 
B
Figure 4. Fragile X Mental Retardation Protein (FMRP) expression in both blood smears 
and hair roots. 
A: Positive appearance in follicle hair roots from normal probands, B: 
Negative appearance in follicle hair roots from full mutation probands, C: 
Positive appearance in lymphocytes cell from normal probands, D: Negative 
appearance in lymphocytes cell from full mutation probands  
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In Blood smears, FMRP expression was shown by brown precipitates in 
lymphocyte whereas FMRP expression in hair roots was shown by Red appearance in 
the sheaths and bulbs. Lymphocytes with negative expression were expressed by grey 
or white expression, as well as negative expression in hair roots (figure 4).  
Table 8. Distribution of percentage of FMRP expression in hair roots and blood   
smear, IQ equivalent, and genotypes (alleles for fragile X). 
No Samples  code  IQ equivalent  % FMRP in blood smear % FMRP in hair roots  Genotypes 
 (Southern blot) 
1  SM001  60  98  85  MR Non Fragile X     * 
2  SM014  65  97  90  MR Non Fragile X    * 
3  SM003  70  95  86  MR Non Fragile X    * 
4 SM006  95  97  89  Normal 
5 SM012  75  88  85  Normal 
6 SM024  75  90  84  Normal 
7 SM007  85  87  82  Normal 
8 SM019  77  97  70  Normal 
9 SM009  75  93  87  Normal 
10 SM028  73  92  86  Normal 
11 SM011  66  75  76  Normal 
12 SM005  80  95  83  Normal 
13 SM030  83  80  73  Premutation 
14 SM021  75  94  85  Premutation 
15 SM015  77  94  77  Premutation 
16 SM004  75  97  80  Premutation 
17 SM010  88  86  90  Premutation 
18 PW001  101  94  85  Premutation 
19 SM018  85  95  82  Premutation 
20 SM008  60  65  50  Full  mutation 
21 SM020  65  65  50  Full  mutation 
22 SM002  60  44  64  Full  mutation 
23 SM022  60  76  40  Full  mutation 
24 SM023  63  63  41  Full  mutation 
25 SM016  70  55  60  Full  mutation 
26 SM025  65  61  54  Full  mutation 
27 SM017  50  97  75  Full  mutation 
28 SM027  85  88  87  Full  mutation 
29 SM026  50  45  31  Full  mutation 
30 SM029  50  58  25  Full  mutation 
31 SM013  55  62  50  Full  mutation 
32 PW002  85  76  69  Full  mutation 
33 SM031  65  67  60  Full  mutation 
* = based on previous research 
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     Normal  samples  and  premutation carriers showed high expression of 
FMRP both in blood smears and hairs roots with an average of 91,78 % and 82,89 %, 
respectively. Three samples of mentally retarded people from non-fragile X also 
showed a high FMRP expression (over 80%), whereas full mutation subjects showed 
on average 65.85 % in blood and 53,98 % in hair roots.  
These findings show that in full mutation individuals the average FMRP 
expression in blood smears was higher than in hair roots. They also indicate that 15 
samples show a different result for FMRP expression in blood smears and hairs over 
10 %, which were mostly in the full mutation group. Comparison of FMRP 






Figure 5. Diagram of percentage of FMRP expression in lymphocytes and hair roots in 
individual samples.  
Non-full mutation groups show high expression of above 75 % except two 
samples, whereas the full mutation group varies from 25 % to 97 %.  The hair 
roots FMRP is lower than in lymphocytes. 
Note :   0 = MR non fragile X 
  1 = normal 
  2 = premutation 
  3 = full mutation  
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To determine whether a relationship exists between the percentage of FMRP 
expression in lymphocytes and hair roots, a correlation test was applied for these 
samples. 







Figure 6. Correlation of FMRP expression between hair roots and lymphocytes in 
total sample (A) and only in full mutation group (B).  
   
 
The Pearson correlation of total sample is highly significant at the 0.01 level    
(r = 0.82, p value < 0.001) and in full mutation group, correlation seems has lower 
value, however it still shows statistical significant at 0.05 level (r = 0.58, P value = 
0.028). This finding informed us that in cells of individual normal, premutation or full 
mutation carriers, FMRP expression look like consistent between lymphocytes and 





A  B  
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4.4.   IQ equivalent of the probands  
Raven Standard Progressive Matrices (SPM) was used to measure IQ 
equivalent of the subjects. A certified psychologist performed the test and also 
further analysis. Results then were depicted in table 8 above and distribution of IQ 










Figure 7.  IQ equivalents (converted from Raven test) distribution in individual 
samples.  
Normals and premutation carriers have an IQ range between 66 and 101, 
whereas full mutation carriers have IQ levels between 50 and 85. The 
average IQ value in Normals and Premutation carriers is 77.88 and 
83.42 respectively, whereas full mutation carriers have 63.07. The 
highest IQ value is 101 in a premutation carrier and the lowest value is 
50 in a full mutation carrier 
 
Thirty percent of the sample shows IQ levels ≥ 80.00, whereas the other 
subjects were below 80. The average value was 77.88 in normal group, 83.42 in 
premutation carriers, and 63.07 in full mutation carriers. In the full mutation group 
there were about 14 % in normal range (≥85), 7 % in the borderline range (70-84) 
and 79 % showed mild mental impairment (50-69).  
 
 
Note :   0 = MR non fragile X 
  1 = normal 
  2 = premutation 
  3 = full mutation  
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4.6. Genotypes of the probands.  
To confirm genotyping of the probands, DNA test using Southern blot 
analysis was performed using a methylation sensitive enzyme that allows us to 
discriminate between methylated and unmethylated FMR1 alleles. This analysis 
also showed us the classification of the alleles, whether it was normal, 
premutation, or full mutation alleles. Result was shown in figure 8 below. Figure 
A and B were using digoxigenine labeled  probe pP2 and Figure C was using 
radioactive labeled probe pAO365. 
 
     5,2 kb 
    2,8 kb 
  
    2,8 kb 
    5,2 kb 
     5,2 kb 
     2,8 kb 
Figure 8. Figure of Southern blotting test from individual samples using double 
digestion with HindIII and EagI. 
A: Lanes 4,14,21 were normal samples. Lanes 1,3,13,20,23 
correspondent to premutation samples whereas full mutation samples 
were shown in lanes 2,5,7,8,9,10,11,12,15,18,19, and 22. Lanes 6 and 
17 indicated full mutation and premutation control, respectively. B: 
Lanes 1,2,5,6,7 were normal samples. Lane 3 correspondents to 
premutation sample and line 4 were full mutation sample. DNA 
ladder was indicated in lane 8. C: Lane 1 was full mutation and lane 2 
was premutation.  
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Normal samples (figure 8A lines 4,14,21 and figure 8B lines 1,2,5,6,7) showed clear 
bands of 2,8 kb and 5,2 kb reflecting unmethylated normal allele and methylated 
normal allele due to X-inactivation process. Full mutation samples showed a high 
smear reflecting of high CGG repeat, except samples in figure 8A lanes 11 and 19 
which were a little bit higher from premutation band. Figures 8A Lanes 7,9,10,15,22, 
and figure 8C lane 1 showed mosaic pattern with a premutation and high smear full 
mutation band. This Southern blotting experiment showed us a distribution of 
samples as follow; 14 samples were full mutation, 7 samples were premutation, and 9 
samples were normal alleles.  
 
4.7.    Correlation between FMRP expression and IQ equivalents of Full 
mutation females. 
 
  In full mutation group, Pearson correlation   test was carried out to determine 
whether a relationship exists between FMRP expression and IQ equivalent. 
 





Figure 9. Correlation between FMRP expression and IQ equivalents in blood 
smear (A) and hair roots (B) in full mutation carriers. 
The chart indicated a significant correlation between percentage of 
FMRP expression in hair roots and IQ equivalents in our group of 
full mutation carriers. 
A  B 
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  The P value of Pearson correlation test for FMRP in hair roots and IQ 
equivalent parameter shows high significance at level 0,05 (P= 0,015) however, the 
correlation of FMRP expression in lymphocytes and IQ equivalents statistically 






















  Mental retardation is one of professional health problem in the world that 
caused by many factors.  Genetics, environment, health status of prenatal, perinatal, 
and postnatal can give rise to cognitive impairment. The absence of FMRP in neurons 
from fragile X patients is the cause of the mental retardation. Thus, FMRP expression 
studies in brain are important to understand the molecular mechanisms underlying the 
disease. For obvious reasons FMRP expression studies in brain are not realistic and 
will be limited to post-mortem material. However, immunocytochemical studies have 
been developed in a diagnostic setting to identify fragile X patients using FMRP 
expression in both lymphocytes from peripheral blood and hair roots. 
  In this study, subjects were obtained from peripheral area based on previous 
study. Semin area is one of district categorizing as minus region by local government. 
Characteristics of the land are bringing on the poverty condition. This is in line with 
several studies that poverty could give rise to low mental development 
56.  All 
subjects varied from children to elderly people; however most of them were older 
than 20 years old.  In the general population it was suggested that mental capability is 
relatively changed due to age increment 
57, however an opposite study was proposed 
that age related cognitive decline could not be established 
58. There are many factors 
to explain about decreased cognitive functioning related to the age.  We could also 
find that most of them were not educated well as 76 % of probands are not educated  
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and only one probands who reach the high school level. Definitely, they have no fix 
occupation since they were only farmer labor. It was represented by the fact that most 
of them were also having limitation in household income. Based Malanom report, it 
was understandable that in many studies, educational background and income 
opportunity also has effect in cognitive development 
59.  
Nutritional status may play a roll in cognitive development as most of them 
have low Body Mass Index. Some report told us that nutritional status represented by 
BMI is related with intelligence quotients, further study 
60 showed that in healthy 
people, BMI also has correlation with cognitive functioning.  However it could not be 
established well as in  another study 
61 showed that BMI had no influence on the IQ 
average to the cognitive functioning in general population. Instead of that, BMI is 
only about the anthropometrics measurement, it does not represent the inner brain 
status. Prominently, mental development looked like is influenced by micronutrients 
such as Fe, Zn, selenium, riboflavin, folat, and I odium 
62, 63. 
   In the past, studies have been reported that FMRP expression in hair roots 
may serve as a predictor of the cognitive functioning of females carrying the fragile X 
full mutation 
9, 10. In contrast, FMRP expression in blood smears can only be used as 
a test to identify male fragile X patients. It has been reported that the test showed 
significant value to distinguish between males with fragile X and normal controls. 
But there was an overlapping result in the female group (full mutation versus 
controls).   
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In this study, first, we tested how long hair roots can be stored after plucking 
and still give reliable results in the hair root test. This is important because hair roots 
should be plucked in Indonesia followed by transport to The Netherlands for analysis. 
We found evidence that hairs can be stored for 14 days at room temperature. This is 
longer than has been reported before 
7. We hypothesize that this is caused by 
differences in the protocols that are used nowadays. Currently antibodies are used 
that show an enhancement of the immunolabeling. In this experiment we used   
mouse powervision poly AP, whereas in the past biotinylated secondary antibody was 
used. Apparently the use of polyvision results in a more sensitive method. 
This result suggested that the hair samples simply could be shipped to 
diagnostic center (Rotterdam) from peripheral area (Indonesia) using courier mail, 
which usually needs one week.  In the first experiment we tested samples from 
Indonesia, which were shipped by courier mail, in a blind fashion. After analysis, we 
found that normal controls showed relatively low FMRP expression in hair roots, 
clearly below the cut-off point (table 7).  This negative result may be caused by 
differences related to local circumstances, including humidity and temperature. In 
addition, conditions of shipment may also influence the quality of samples. This 
result prompted us to perform hair roots analysis in Indonesia with fresh hair roots. 
This research found evidence that all the samples from female normal and 
premutation carriers expressed normal levels of FMRP (75 -100%) both in blood 
smears and hair roots, whereas full mutation female carriers showed a great variance 
in percentage of FMRP expression (figure 5). This finding is in line with the current  
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hypothesis that normal and premutation carriers show a normal translation of the 
FMR1 mRNA. In contrast to carriers of the full mutation alleles that usually shows a 
methylation of the FMR1 gene, resulting in lack of FMRP. A random lyonization 
process that occurred in the cells causes the variance of FMRP expression in female 
full mutation.  
Normal and premutation subjects in this study show rather low IQ 
equivalents. A possible explanation for this observation is that they live in an isolated 
area where modern facilities are limited. Most of them are not educated and living in 
a simple environment. Also the diet may play a role because they eat more cassava 
than rice because of dry area. As a consequence they eat very less protein, which may 
harm the body because of cyanine in the cassava. In line, this finding represents the 
condition that they may have low micronutrient intake causing low support of brain 
normal development.  It is also in line with previous literature mentioning that diet 
intake can influence in cognitive functioning development 
64.Hypothyroidism is also 
one of problems in these areas 
65. Also we experienced that during completing the 
Raven test; we had to explain the test more frequently. In contrast, they finished their 
test very fast. This case relates with a previous study that mentioned  alternative 
hypothesis to general ability (g) for why non-Western population score lower than 
Western population; such as test-wise, less interested, more anxious, work less 
efficiently, or give up sooner on items they find difficult 
66.  
Distributions of IQ equivalent in the full mutation group were about 14 % in 
normal range (≥85), 7 % in the borderline range (70-84) and 79 % showed mild  
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mental impairment (50-69). This finding is higher than previous research that 
mentioned about 60 % with mild mental retardation; however, in our studies the 
number of subjects was limited and should be expanded in the near future to draw 
final conclusions. This study also suggests that in this isolated area, less difference in 
mental capacities occurs between mentally retarded people and normal people. Figure 
7 clearly informed us the difference in IQ equivalents of the full mutation, 
premutation, and normal groups.  
In the full mutation group we found subjects that have relatively high IQ 
levels compared to others showing higher FMRP expression in their cells (compared 
with another samples). It can be described by the fact that females carrying a full 
mutation are characterized by cells with and without FMRP expression, which can be 
explained by the presence of two X-chromosomes and random inactivation of one of 
the X chromosome (Lyonisation). This finding also noticed that although human 
intelligence is influenced by many genetic factors, a single mutation in the FMR1 
gene resulting in lack of FMRP significantly reduces cognitive functioning in female 
full mutation carriers 
10. 
The result of FMRP expression in blood smears and hair roots also correlated 
with each other, although FMRP expression in blood smears seemed to be higher than 
in hair roots. This may be explained by differences of origin. Blood originate from 
mesoderm layer whereas hair roots like brain tissue from the ectoderm. Blood, 
especially lymphocytes, originate from a common lymphoid progenitor cell before 
differentiating into their distinct lymphocyte types. The formation of lymphocytes  
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which is known as lymphopoiesis will turn every day and will live for weeks till 
years 
67.  
It has also been suggested that there might be a selection against cells with a 
full mutation in dividing lymphocytes or that there is a bias toward inactivation of the 
X-chromosome in women during aging 
68. This may explain why there might be a 
better correlation between (the lack of) FMRP expression in hair roots and mental 
retardation. In addition, lymphocytes may show less reflection of the situation in 
brain
 tissue, because the rapid turnover may lead to high variation in clones that either 
carry the FMR1
 mutation on the active X chromosome or do not. Earlier studies
 using 
the FMRP test on lymphocytes did show a weak statistical
 correlation; however, the 
significance was not high enough to
  use this method as a reliable diagnostic or 
predictive test 
10. 
The benefit of hair roots as a diagnostic tool is shown in this study because we 
found, although in a small-sized study, a highly significant correlation between the 
percentage of FMRP expression in hair roots and IQ equivalent in female full 
mutation carriers. The statistical analysis showed us that level of cognitive 
functioning in female full mutation carriers typically are reflected by FMRP in hair 
roots than in blood smears. The origin of the tissue is important, however, 
methodological aspect may play a role as well and cannot be excluded from this 
research.  
In summary we show that FMRP expression in hair roots is probably more 
useful to predict cognitive functioning in female full mutation carriers than blood,  
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however, the number of full mutation carriers tested in this study is too low to draw 

























CONCLUSIONS AND SUGGESTIONS 
 
6.1  Conclusions  
1.  There was strong relationship between FMRP expression in hair roots 
and cognitive functioning in female carriers of the fragile X full 
mutation. 
2.  FMRP expression in hair roots had stronger correlation for cognitive 
functioning than FMRP expression in blood smears. 
3.  IQ equivalent in female fragile X full mutation group were about 14 % 
in normal range, 7 % in borderline range and 79 % in mild mental 
impairment. 
6.2  Future directions 
1.  Since sample size of this study is relatively limited, it is suggested to 
conduct next study using bigger sample to make statements about the 
reliability of the FMRP test and cognitive functioning in the female 
full mutation carriers. 
2.  Based on the result of this study that FMRP expression in hair roots 
has stronger correlation, non-invasive test, and can be performed in a 
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2. Figures of FMRP expressions in follicles of hair roots 
A 
B 
Figure A : Positives FMRP expressions in follicles of hair roots 
Red appearance in the bulb of hair follicle and sheath reflects FMRP expression 
(white arrow), and black appearance showed negative FMRP (black arrow)  
Figure B : Negative FMRP expressions in follicles of hair roots. 
No red sign in the bulb of hair follicle reflects no FMRP expression  

























3. Figures of FMRP expressions in blood smears 
Figure B : Negative FMRP expressions in blood smears. 
Grey appearance of cytoplasm indicates that there is no FMRP expression in 
lymphocytes (black arrow). 
B 
Figure A : Positives FMRP expressions in blood smears. 
Brown precipitate in the cytoplasm shows FMRP expression in lymphocytes. 
(black arrow)  
A  